BOSTON, MA, May 12th, 2020 –
HD LifeSciences has received 510(k) clearance from the U.S Food and Drug Administration (FDA) for its Hive™ ALIF Standalone Lumbar Interbody Fusion System. The patented implant system features a modular anterior portion that allows surgeon choice and flexibility in using integrated zero-profile fixation or anterior plating. The implant also features a patent-pending mechanism that allows the surgeon to adjust the footprint of the device pre-implantation to better match patient anatomy.
“This system is the next step forward for HD’s Hive™ implants,” says David Rattigan, Vice President of Sales for HD LifeSciences. “We are proud to offer this differentiated implant technology to our surgeon users.”
The Hive™ ALIF Standalone System will offer surgeons a variety of implant configurations, with multiple width, height, depth, and lordotic choices to accommodate patient needs.
About HD LifeSciences
HD Lifesciences is transforming orthopedic care with our Hive™ Soft Titanium® technology. The Hive™ lattice with NanoHive® Surface Technology provides ideal elastic modulus, diagnostic imaging, and osteogenic properties. Founded with a mission to improve surgical methods and devices, HD LifeSciences brings together science and engineering to improve patient care.
HiveTM ALIF Standalone System Press Release/DCO 20-011
